Stock Events

Stock Events

MeiraGTx 

$8.47
18
+$0.00+0%Friday 01:12

Statistics

Day High
8.47
Day Low
8.47
52W High
13.5
52W Low
8.47
Volume
12
Avg. Volume
-
Mkt Cap
813.48M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 18Expected
Q3 2025
Q1 2026
Q2 2026
Next
-0.62
0.16
0.93
1.71
Expected EPS
-0.5
Actual EPS
N/A

Financials

-140.31%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
81.39MRevenue
-114.2MNet Income

Analyst Ratings

$21.00Average Price Target
The highest estimate is ⁦27.00⁩.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MGTX.BOATS. It's not an investment recommendation.
NVIDIA
6
NVDA
AMD
6
AMD
Realty Income
5
O
Bitcoin
5
BTC.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical develops gene therapies for rare genetic diseases, overlapping with MeiraGTx's target indications.
Pfizer
PFE
Mkt Cap173.95B
Pfizer has a growing interest in gene therapy, making it a competitor as it expands into MeiraGTx's areas of focus.
Abeona Therapeutics
ABEO
Mkt Cap248.75M
Abeona Therapeutics works on cell and gene therapies for genetic diseases, directly competing with MeiraGTx's therapeutic areas.
Novartis
NVS
Mkt Cap303.67B
Novartis has gene therapy products and a strong pipeline in areas that overlap with MeiraGTx's interests, making it a significant competitor.

About

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Show More
CEO
ISIN
KYG596651029

Listings

STU
DE
328.STU
MU
DE
328.MU
XNAS
US
MGTX
F
DE
328.F

0 Comments

Share your thoughts

FAQs

What is MeiraGTx stock price today?▼
The current price of MGTX.BOATS is $8.47 USD — it has increased by +0% in the past 24 hours. Watch MeiraGTx stock price performance more closely on the chart.
What is MeiraGTx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange MeiraGTx stocks are traded under the ticker MGTX.BOATS.
What is MeiraGTx market cap?▼
Today MeiraGTx has the market capitalization of 813.48M
When is the next MeiraGTx earnings date?▼
MeiraGTx is going to release the next earnings report on November 18, 2026.
What were MeiraGTx earnings last quarter?▼
MGTX.BOATS earnings for the last quarter are 1.71 USD per share, whereas the estimation was -0.46 USD resulting in a +473.09% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MeiraGTx revenue for the last year?▼
MeiraGTx revenue for the last year amounts to 81.39M USD.
What is MeiraGTx net income for the last year?▼
MGTX.BOATS net income for the last year is -114.2M USD.
In which sector is MeiraGTx located?▼
MeiraGTx operates in the Other sector.
When did MeiraGTx complete a stock split?▼
MeiraGTx has not had any recent stock splits.